Mechanistically, by robustly attenuating STING signaling cascades and HK2-driven glycolysis, LDO actively down-regulates macrophage chemokine signaling pathways, especially CCL2, thus opening new avenues for targeted interventions in sepsis management. Here, CCL2 is linked to Sepsis.